2 completed, 2 unknown, 1 terminated. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Unknown 2, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Adverse Event: new trials by email Literature Review of Adverse Event trials Research Report on Adverse Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Versus Conventional Cessation of Hydrocortisone in Septic Shock normal saline solution, Hydrocortisone and normal saline solution - Septic Shock, Adverse Event | Phase 2 | Unknown | Mahidol University | 160 | 2023-07-05 | 2024-04-05 |
| Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions ePRO Application - Multiple Chronic Conditions, Adverse Event | Phase 1 / Phase 2 | Terminated | Brigham and Women's Hospital | 937 | 2022-02-01 | 2026-10-21 |
| Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT) Acalabrutinib 2x100 MG Oral Capsule + alloSCT - Chronic Lymphocytic Leukemia, Chronic Graft-versus-host-disease | Phase 2 | Completed | Polish Lymphoma Research Group | 29 | 2019-08-19 | 2025-01-16 |
| Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin Akynzeo, Dexamethasone - Chemotherapy-induced Nausea and Vomiting, Adverse Event | Phase 2 / Phase 3 | Unknown | Christina Ruhlmann | 80 | 2018-09-05 | 2021-12-14 |
| LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy Lifemel - Neutropenia, Adverse Event | Phase 2 | Completed | VitalMel | 39 | 2013-11-11 | 2020-09-24 |
Bronchiolitis Obliterans Syndrome (1) · Hyperglycemia (1) · Hypernatremia (1) · Leukemia, B-Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, Mantle-Cell (1) · Multiple Chronic Conditions (1) · Muscle Weakness (1) · Neoplasm, Residual (1) · Neutropenia (1) · Shock, Septic (1) · Superinfection (1) · Uterine Cervical Neoplasms (1) · Vomiting (1)
Pathological Conditions, Signs and Symptoms (4) · Pathologic Processes (3) · Chronic Disease (2) · Disease Attributes (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms (2) · Signs and Symptoms (2) · Agranulocytosis (1) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Cytopenia (1) · Female Urogenital Diseases (1)
Dexamethasone (1) · Hydrocortisone (1) · Saline Solution (1) · netupitant, palosentron drug combination (1)
Brigham and Women's Hospital (1) · Christina Ruhlmann (1) · Mahidol University (1) · Polish Lymphoma Research Group (1) · VitalMel (1)
Denmark (1) · Poland (1) · Thailand (1) · United States (1)
Andrea Pietro Sponghini (1) · Anuj Dalal, MD (1) · Christina H. Ruhlmann, MD, PhD (1) · Sebastian Giebel, Prof. (1) · Surat Tongyoo, Doctor (1)